Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01232946 · ClinicalTrials.gov registry record · NA
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01232946 is a NA study that has completed, run by Indiana University. The registered enrollment target is 30 participants.
The verdict
NCT01232946, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
27 Type 2 diabetic subjects (HbA1c 7.5 - 9.5%) currently treated with diet and exercise alone or with oral antidiabetic agents will be randomly assigned to one of three treatment groups: insulin detemir, liraglutide, or liraglutide plus detemir (9 subjects per group), on a background of metformin 2000 mg per day. After 3 months' treatment, PET measurements of myocardial fuel selection will take place, under fasting conditions in the morning following that day's treatment injection(s).
Interventions
- DRUG liraglutide
- DRUG insulin detemir
- DRUG liraglutide plus insulin detemir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01232946
The ClinicalTrials.gov registry entry for NCT01232946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which liraglutide is the first listed.
NCT01232946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01232946 about?
NCT01232946 is a clinical study titled "Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake". 27 Type 2 diabetic subjects (HbA1c 7.5 - 9.5%) currently treated with diet and exercise alone or with oral antidiabetic agents will be randomly assigned to one of three treatment groups: insulin detemir, liraglutide, or liraglutide plus detemir (9 subjects per group), on a background of metformin 20...
What is the current status of trial NCT01232946?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-01. Estimated completion is 2017-09-08.
What interventions are being tested in trial NCT01232946?
The interventions under investigation include: liraglutide (DRUG), insulin detemir (DRUG), liraglutide plus insulin detemir (DRUG).
Who is sponsoring clinical trial NCT01232946?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.